BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12798651)

  • 21. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.
    Planelles L; Thomas MC; Alonso C; López MC
    Infect Immun; 2001 Oct; 69(10):6558-63. PubMed ID: 11553607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.
    Araújo AF; de Alencar BC; Vasconcelos JR; Hiyane MI; Marinho CR; Penido ML; Boscardin SB; Hoft DF; Gazzinelli RT; Rodrigues MM
    Infect Immun; 2005 Sep; 73(9):6017-25. PubMed ID: 16113322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.
    Barbosa RP; Filho BG; Dos Santos LI; Junior PA; Marques PE; Pereira RV; Cara DC; Bruña-Romero O; Rodrigues MM; Gazzinelli RT; Machado AV
    PLoS One; 2013; 8(4):e61795. PubMed ID: 23637908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
    Bontempi I; Fleitas P; Poato A; Vicco M; Rodeles L; Prochetto E; Cabrera G; Beluzzo B; Arias D; Racca A; Guerrero S; Marcipar I
    Immunotherapy; 2017 Jun; 9(7):555-565. PubMed ID: 28595515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
    Chou B; Hiromatsu K; Hisaeda H; Duan X; Imai T; Murata S; Tanaka K; Himeno K
    Biochem Biophys Res Commun; 2010 Feb; 392(3):277-82. PubMed ID: 20059980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.
    Costa F; Franchin G; Pereira-Chioccola VL; Ribeirão M; Schenkman S; Rodrigues MM
    Vaccine; 1998 May; 16(8):768-74. PubMed ID: 9627933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.
    Tzelepis F; de Alencar BC; Penido ML; Gazzinelli RT; Persechini PM; Rodrigues MM
    Infect Immun; 2006 Apr; 74(4):2477-81. PubMed ID: 16552083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection.
    Boscardin SB; Kinoshita SS; Fujimura AE; Rodrigues MM
    Infect Immun; 2003 May; 71(5):2744-57. PubMed ID: 12704149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific humoral and cellular immunity induced by Trypanosoma cruzi DNA immunization in a canine model.
    Arce-Fonseca M; Ballinas-Verdugo MA; Zenteno ER; Suárez-Flores D; Carrillo-Sánchez SC; Alejandre-Aguilar R; Rosales-Encina JL; Reyes PA; Rodríguez-Morales O
    Vet Res; 2013 Mar; 44(1):15. PubMed ID: 23497041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
    Bhatia V; Garg NJ
    Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase.
    Machado AV; Cardoso JE; Claser C; Rodrigues MM; Gazzinelli RT; Bruna-Romero O
    Hum Gene Ther; 2006 Sep; 17(9):898-908. PubMed ID: 16972758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.
    Sepulveda P; Hontebeyrie M; Liegeard P; Mascilli A; Norris KA
    Infect Immun; 2000 Sep; 68(9):4986-91. PubMed ID: 10948115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen.
    Millar AE; Kahn SJ
    Infect Immun; 2000 Jun; 68(6):3574-80. PubMed ID: 10816514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity.
    Quanquin NM; Galaviz C; Fouts DL; Wrightsman RA; Manning JE
    Infect Immun; 1999 Sep; 67(9):4603-12. PubMed ID: 10456906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
    de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
    Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.
    Ouaissi A; Guilvard E; Delneste Y; Caron G; Magistrelli G; Herbault N; Thieblemont N; Jeannin P
    J Immunol; 2002 Jun; 168(12):6366-74. PubMed ID: 12055254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection.
    Luhrs KA; Fouts DL; Manning JE
    Vaccine; 2003 Jun; 21(21-22):3058-69. PubMed ID: 12798650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
    Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
    Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection.
    Miyahira Y; Takashima Y; Kobayashi S; Matsumoto Y; Takeuchi T; Ohyanagi-Hara M; Yoshida A; Ohwada A; Akiba H; Yagita H; Okumura K; Ogawa H
    Infect Immun; 2005 Nov; 73(11):7356-65. PubMed ID: 16239534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.